Acute attacks
Sudden attacks of hereditary angioedema.
Clinical trials
Studies that evaluate the effectiveness and safety of medications or medical devices before they are approved for use by the general public.
Ecallantide (e-KAL-lan-tide)
A protein made in yeast cells; ecallantide is the active ingredient in KALBITOR (ecallantide).
HAE
Abbreviation for hereditary angioedema.
Hereditary Angioedema
A rare, hereditary disease of the immune system that causes attacks of sudden swelling in various parts of the body.
KALBITOR Access®
KALBITOR Access is a program that provides support services to hereditary angioedema patients, healthcare professionals and caregivers. KALBITOR Access services include health insurance coordination, financial assistance for qualified patients, and treatment location set up.
KALBITOR CareSM
KALBITOR Care is a program offered by Dyax Corp. that provides comprehensive support services for KALBITOR patients. Available 24 hours a day, 7 days a week, KALBITOR Care offers a complete array of patient services and resources, along with the support of healthcare professionals.
KALBITOR Home Infusion ServicesSM
KALBITOR Home Infusion Services is a program in which an experienced infusion nurse will administer your subcutaneous KALBITOR treatment in the comfort of your own home. This professional service is available to HAE patients, 16 years of age or older, who use KALBITOR to treat their sudden HAE attacks on demand. KALBITOR Home Infusion Services is not appropriate for treating laryngeal attacks.
KALBITOR® (KAL-bit-or)
A prescription medicine used to treat sudden attacks of hereditary angioedema in patients 16 years of age and older. KALBITOR® is not a cure for HAE.
Laryngeal attack
An HAE attack that affects the larynx (throat); this can block or close the airway, leading to difficulty breathing and, potentially, death.
Larynx
The part of the throat that contains the vocal cords and is used for breathing, swallowing, and talking.
On-demand treatment
On-demand HAE treatment is used to treat sudden attacks of HAE as they occur, in order to relieve symptoms associated with the attack. On-demand treatment is not used to prevent attacks from occurring.
Plasma kallikrein (kal'i-kre'in)
A protein in the body that triggers the release of a substance that may lead to hereditary angioedema attack symptoms.
Subcutaneous
Under the skin.
Trigger
In hereditary angioedema, something that causes an attack.
Please note:

The web site you are about to visit is neither owned nor controlled by Dyax Corp. Dyax is not responsible for the content, products or services on this site.

Do you wish to continue?

Please note:

You are about to leave the KALBITOR website to visit another
site that contains Dyax-managed content.

Do you wish to continue?

 

call TOLL-FREE (1-888-452-5248)

1-888-4KALBITOR

 

Am I the only person with HAE?

I used to ask myself this question, but with KALBITOR CareSM I have tools and resources to stay connected and meet others affected by this disease.

Please see Full Prescribing Information, including Boxed Warning and Medication Guide. 

Glossary

  • Acute attacks

    Sudden attacks of hereditary angioedema.

  • Clinical trials

    Studies that evaluate the effectiveness and safety of medications or medical devices before they are approved for use by the general public.

  • Ecallantide (e-KAL-lan-tide)

    A protein made in yeast cells; ecallantide is the active ingredient in KALBITOR (ecallantide).

  • HAE

    Abbreviation for hereditary angioedema.

  • Hereditary Angioedema

    A rare, hereditary disease of the immune system that causes attacks of sudden swelling in various parts of the body.

  • KALBITOR Access®

    KALBITOR Access is a program that provides support services to hereditary angioedema patients, healthcare professionals and caregivers. KALBITOR Access services include health insurance coordination, financial assistance for qualified patients, and treatment location set up.

  • KALBITOR CareSM

    KALBITOR Care is a program offered by Dyax Corp. that provides comprehensive support services for KALBITOR patients. Available 24 hours a day, 7 days a week, KALBITOR Care offers a complete array of patient services and resources, along with the support of healthcare professionals.

  • KALBITOR Home Infusion ServicesSM

    KALBITOR Home Infusion Services is a program in which an experienced infusion nurse will administer your subcutaneous KALBITOR treatment in the comfort of your own home. This professional service is available to HAE patients, 16 years of age or older, who use KALBITOR to treat their sudden HAE attacks on demand. KALBITOR Home Infusion Services is not appropriate for treating laryngeal attacks.

  • KALBITOR® (KAL-bit-or)

    A prescription medicine used to treat sudden attacks of hereditary angioedema in patients 16 years of age and older. KALBITOR® is not a cure for HAE.

  • Laryngeal attack

    An HAE attack that affects the larynx (throat); this can block or close the airway, leading to difficulty breathing and, potentially, death.

  • Larynx

    The part of the throat that contains the vocal cords and is used for breathing, swallowing, and talking.

  • On-demand treatment

    On-demand HAE treatment is used to treat sudden attacks of HAE as they occur, in order to relieve symptoms associated with the attack. On-demand treatment is not used to prevent attacks from occurring.

  • Plasma kallikrein (kal'i-kre'in)

    A protein in the body that triggers the release of a substance that may lead to hereditary angioedema attack symptoms.

  • Subcutaneous

    Under the skin.

  • Trigger

    In hereditary angioedema, something that causes an attack.

Save & Reload to see changes.

Hide the "Print / Email" Section

Print Page |

Please make sure to read
Important Safety
Information for KALBITOR.

safety information

Discover how KALBITOR works to treat sudden HAE attacks.

learn more

Keep on top of HAE news with KALBITOR Care. Sign up to receive the latest updates about KALBITOR, services, and community events.

sign up now
 
 
 
KALBITOR is a prescription medicine used to treat sudden attacks of hereditary angioedema (HAE) in patients 16 years of age and older. KALBITOR is not a cure for HAE.
Important Safety Information EXPAND ›

KALBITOR® (ecallantide) for subcutaneous use should only be given by a doctor or nurse with appropriate medical support to treat serious allergic reactions and your hereditary angioedema. You should read the Medication Guide before you start receiving KALBITOR and before each treatment.

Serious allergic reactions may happen in some people who receive KALBITOR. These allergic reactions can be life-threatening and usually happen within 1 hour after receiving KALBITOR.

Symptoms of a serious allergic reaction to KALBITOR can be similar to the symptoms of hereditary angioedema, the condition that you are being treated for. Your doctor or nurse should watch you for any signs of a serious allergic reaction after treatment with KALBITOR. Tell your doctor or nurse right away if you have any of these symptoms of a serious allergic reaction during or after treatment with KALBITOR:

  • wheezing, shortness of breath, cough, chest tightness, or trouble breathing
  • dizziness, fainting, fast or weak heartbeat, or feeling nervous
  • reddening of the face, itching, hives, or feeling warm
  • swelling of the throat or tongue, throat tightness, hoarse voice, or trouble swallowing
  • runny nose or sneezing

Do not receive KALBITOR if you are allergic to KALBITOR. Before receiving KALBITOR, tell your doctor if you have ever had an allergic reaction to KALBITOR.

Before receiving KALBITOR, tell your doctor about all of your health conditions, including any allergies you may have, whether you are pregnant, plan to become pregnant, or are breast feeding or plan to breast feed. It is not known if KALBITOR will harm your unborn baby or if KALBITOR passes into your breast milk.

Common side effects of KALBITOR include headache, nausea, diarrhea, fever, injection site reactions, such as redness, rash, swelling, itching, or bruising, and stuffy nose.

Talk to your doctor for more information and if you have any questions about your treatment.

Please see Full Prescribing Information, including Boxed Warning and Medication Guide.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.